Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 248

1.

Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes.

Campagna D, Cibella F, Caponnetto P, Amaradio MD, Caruso M, Morjaria JB, Malerba M, Polosa R.

Eur J Clin Invest. 2016 Jun 20. doi: 10.1111/eci.12651. [Epub ahead of print]

PMID:
27322745
2.

E-cigarettes are less harmful than smoking.

Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Polosa R, Ramsey J, Sweanor D.

Lancet. 2016 Mar 19;387(10024):1160-2. doi: 10.1016/S0140-6736(15)00253-6. No abstract available.

PMID:
27025332
3.

Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes.

Polosa R, Morjaria JB, Caponnetto P, Caruso M, Campagna D, Amaradio MD, Ciampi G, Russo C, Fisichella A.

Discov Med. 2016 Feb;21(114):99-108.

4.

Comments on Scheffler et al. Cytotoxic Evaluation of E-Liquid Aerosol using Different Lung Derived Cell Models. Int. J. Environ. Res. Public Health, 2015, 12, 12466-12474.

Polosa R, Caruso M, Guarino F.

Int J Environ Res Public Health. 2016 Jan 6;13(1). pii: E108. doi: 10.3390/ijerph13010108.

5.

Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes.

Farsalinos K, Cibella F, Caponnetto P, Campagna D, Morjaria JB, Battaglia E, Caruso M, Russo C, Polosa R.

Intern Emerg Med. 2016 Feb;11(1):85-94. doi: 10.1007/s11739-015-1361-y. Epub 2016 Jan 9.

6.

Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes.

Russo C, Cibella F, Caponnetto P, Campagna D, Maglia M, Frazzetto E, Mondati E, Caruso M, Polosa R.

Sci Rep. 2016 Jan 5;6:18763. doi: 10.1038/srep18763.

7.

Evaluation of Chronic Obstructive Pulmonary Disease (COPD) attributed to atmospheric O3, NO2, and SO2 using Air Q Model (2011-2012 year).

Ghanbari Ghozikali M, Heibati B, Naddafi K, Kloog I, Oliveri Conti G, Polosa R, Ferrante M.

Environ Res. 2016 Jan;144(Pt A):99-105. doi: 10.1016/j.envres.2015.10.030. Epub 2015 Nov 21.

PMID:
26599588
8.

Counseling patients with asthma and allergy about electronic cigarettes: an evidence-based approach.

Polosa R, Campagna D, Sands MF.

Ann Allergy Asthma Immunol. 2016 Feb;116(2):106-11. doi: 10.1016/j.anai.2015.10.012. Epub 2015 Oct 27. Review.

PMID:
26522253
9.

What to advise to respiratory patients intending to use electronic cigarettes.

Polosa R, Campagna D, Caponnetto P.

Discov Med. 2015 Sep;20(109):155-61.

10.

An uncommon cause of syncope.

Campagna D, Amaradio MD, Battaglia E, Demma S, Russo C, Polosa R.

Intern Emerg Med. 2016 Apr;11(3):425-9. doi: 10.1007/s11739-015-1317-2. Epub 2015 Sep 25.

PMID:
26407606
11.

E-cigarettes: Public Health England's evidence based confusion?

Polosa R.

Lancet. 2015 Sep 26;386(10000):1237-8. doi: 10.1016/S0140-6736(15)00133-6. Epub 2015 Sep 4. No abstract available.

PMID:
26346249
12.

Impact of air quality on lung health: myth or reality?

Marino E, Caruso M, Campagna D, Polosa R.

Ther Adv Chronic Dis. 2015 Sep;6(5):286-98. doi: 10.1177/2040622315587256. Review.

13.

Electronic cigarette use and harm reversal: emerging evidence in the lung.

Polosa R.

BMC Med. 2015 Mar 18;13:54. doi: 10.1186/s12916-015-0298-3.

14.

What to consider when regulating electronic cigarettes: Pros, cons and unintended consequences.

Caponnetto P, Saitta D, Sweanor D, Polosa R.

Int J Drug Policy. 2015 Jun;26(6):554-9. doi: 10.1016/j.drugpo.2015.03.001. Epub 2015 Mar 14.

PMID:
25857204
15.

Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey.

Polosa R, Caponnetto P, Cibella F, Le-Houezec J.

Int J Environ Res Public Health. 2015 Mar 24;12(4):3428-38. doi: 10.3390/ijerph120403428.

16.

Commentary on Dawkins et al. (2015): electronic cigarettes - from smoking cessation to smoking sensation and back.

Caponnetto P, Maglia M, Polosa R.

Addiction. 2015 Apr;110(4):678-9. doi: 10.1111/add.12854. No abstract available.

PMID:
25771692
17.

Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis.

Del Papa N, Caviggioli F, Sambataro D, Zaccara E, Vinci V, Di Luca G, Parafioriti A, Armiraglio E, Maglione W, Polosa R, Klinger F, Klinger M.

Cell Transplant. 2015;24(1):63-72. doi: 10.3727/096368914X674062.

PMID:
25606975
18.

Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trial.

Polosa R, Bellinvia S, Caruso M, Emma R, Alamo A, Kowalski ML, Domingo C.

Trials. 2014 Dec 18;15:492. doi: 10.1186/1745-6215-15-492.

19.

Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.

Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C.

BMC Public Health. 2014 Nov 8;14:1159. doi: 10.1186/1471-2458-14-1159.

20.

Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis.

Sambataro D, Sambataro G, Zaccara E, Maglione W, Polosa R, Afeltra AM, Vitali C, Del Papa N.

Arthritis Res Ther. 2014 Oct 9;16(5):462. doi: 10.1186/s13075-014-0462-8.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk